1315 Capital Announces the Addition of Senior Investment Professional

Wednesday, June 7, 2017 Senior Health News
Email Print This Page Comment bookmark
Font : A-A+

Matthew Reber joins Philadelphia-based healthcare growth capital firm as a Partner

PHILADELPHIA, June 7, 2017 /PRNewswire/ --1315 Capital, LLC, an expansion and growth equity firm that invests in

commercial-stage specialty pharmaceutical, medical technology, and healthcare services companies, announced today the continued expansion of its senior investment team with the addition of Matthew Q. Reber as a Partner. Mr. Reber joins Founding Partners, Adele C. Oliva and Michael Koby, and brings deep healthcare investing experience across equity and debt transactions to 1315 Capital.

"Matt's extensive transaction expertise and entrepreneurial spirit will help us continue to build 1315 Capital as a nationally recognized leader in healthcare expansion and growth equity," said Oliva.

Mr. Reber joins 1315 Capital after spending nine years at HealthCare Royalty Partners, most recently as a Managing Director. He has fifteen years of growth stage investing experience with a focus on the specialty pharmaceutical and medical technology sectors. Mr. Reber has worked on over $1 billion in healthcare financings over the course of his career.

"I am excited to return to Philadelphia and have the opportunity to build on the tremendous success already achieved at 1315 Capital," said Reber."While we focus nationally, the richness of entrepreneurial activity and experienced management teams in the region provides an ideal backdrop to establish a leading growth and expansion stage healthcare investment firm."

Mr. Reber holds a Bachelor of Science in Engineering degree, magna cum laude, from Princeton University, a Master of Business Administration degree with honors from The Wharton School of the University of Pennsylvania, and a Master of Biotechnology degree from the University of Pennsylvania.

About 1315 Capital1315 Capital provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare services companies. 1315 Capital leverages experienced investors and proven operating teams to work alongside portfolio company management to rapidly grow platform companies into high value businesses that positively impact patients, physicians, and the broader healthcare system. For more information, visit http://www.1315capital.com.

Contact InformationAlyson Kuritz, Zer0 to 5ive for 1315 [email protected] 908-8927149

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/1315-capital-announces-the-addition-of-senior-investment-professional-300470063.html

SOURCE 1315 Capital, LLC



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook